Arrhythmogenic right ventricular cardiomyopathy: an update

Heart

Volumn 95, Issue 9, 2009, Pages 766-773

  Corrado, Domenico ^a   Basso, Cristina ^a   Thiene, Gaetano ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SOTALOL;

ARTICLE; CARDIOVASCULAR RISK; CATHETER ABLATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DISEASE COURSE; ELECTROCARDIOGRAPHY; GENETIC ANALYSIS; HEART FAILURE; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICULOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; TREATMENT RESPONSE; DESMOSOME; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; HEART RIGHT VENTRICLE FUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; MUTATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SUDDEN DEATH;

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DEATH, SUDDEN, CARDIAC; DESMOSOMES; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MAGNETIC RESONANCE ANGIOGRAPHY; MUTATION; RISK FACTORS; VENTRICULAR FUNCTION, RIGHT;

EID: 65549161398     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.149823     Document Type: Article

References (24)

1. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 2000;83:588-95.
2. Marcus F, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Milan: Springer, 2007.
3. Corrado D, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 2006;113:1634-7.
4. McKoy G, Protonotarios N, Crosby A, et al . Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24.
5. Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002;71:1200-6.
6. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004;36:1162-1.
7. Pilichou K, Nava A, Basso C, et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 2006;113:1171-9.
8. Syrris P, Ward D, Evans A, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 2006;79:978-84.
9. Thiene G, Corrado D, Basso C. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphsnet J Rsre Dis 2007;2:45.
10. Basso C, Czarnowska E, Della Barbera M, et al. Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Hesrt J 2006;27:1847-54.
11. Garcia-Gras E, Lombardi R, Giocondo MJ, et al. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Ciin Invest 2006;116:2012-21.
12. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-601.
13. Hamid MS, Norman M, Quraishi A, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coii Csrdioi 2002;40:1445-50.
14. Basso C, Ronco F, Marcus F, et al. Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Hesrt J 2008;29:2760-71.
15. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coii Csrdioi 2005;45:98-103.
16. Sen-Chowdhry S, Prasad SK, Syrris P, et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coii Csrdioi 2006;48:2132-40.
17. Corrado D, Basso C, Leoni L, et al. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circuistion 2005;111:3042-50.
18. Corrado D, Basso C, Leoni L, et al. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coii Csrdioi 2008;51:731-9.
19. Verma A, Kilicaslan F, Schweikert RA, et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circuistion 2005;111:3209-16.
20. Buja G, Estes NA 3rd, Wichter T, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy. Prog Csrdiovssc Dis 2008;50:282-93.
21. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter- defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circuistion 2003;108:3084-91.
22. Wichter T, Paul M, Wollmann C, et al. Implantable cardioverter/ defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circuistion 2004;109:1503-8.
23. Roguin A, Bomma CS, Nasir K, et al. Implantable cardioverter- defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coii Csrdioi 2004;43:1843-52.
24. Dalal D, Jain R, Tandri H, et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Co Csrdio 2007;50:432-40.